(Q36728823)

15 August 2017

1 reference

title

Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors (English)

1 reference

15 August 2017

1 reference

1 reference

Vanessa L Gates

1

0 references

Riad Salem

object named as

Riad Salem

8

0 references

Reed A. Omary

7

object named as

Reed Omary

1 reference

15 August 2017

Bassel Atassi

2

1 reference

15 August 2017

Robert J Lewandowski

3

1 reference

15 August 2017

Robert K Ryu

4

1 reference

15 August 2017

Kent T Sato

5

1 reference

15 August 2017

Albert A Nemcek

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

73-81

1 reference

Effects of hepatic arterial yttrium 90 glass microspheres in dogs

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic im

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Salvage surgery following downstaging of unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Surgical treatment of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Angiographic considerations in patients undergoing liver-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Analysis of radiation-induced liver disease using the Lyman NTCP model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Portal hypertension secondary to 90Yttrium microspheres: an unknown complication

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.3.1.73

21 January 2018

Identifiers

DOI

10.2217/14796694.3.1.73

1 reference

15 August 2017

1 reference